查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1749707

軟體凝膠膠囊的全球市場:各材料類型，來歷，各用途，各終端用戶，各地區，機會，預測，2018年～2032年

Global Softgel Capsules Market Assessment, By Material Type, By Source, By Application, By End-user, By Region, Opportunities and Forecast, 2018-2032F
出版日期: | 出版商: Markets & Data | 英文 229 Pages | 商品交期: 3-5個工作天內

價格

全球軟膠囊市場預計將從2024年的23.4億美元成長至2032年的35.8億美元，在2025-2032年的預測期內，複合年增長率為5.45%。市場發展的動力源於製藥業的快速擴張、研發投入的不斷增加以及對新產品和新技術引進的日益重視。軟膠囊通常因其易於吞嚥、生物利用度更高以及能夠掩蓋異味和異味而備受青睞。消費者對ω-3脂肪酸、維生素和草藥等食品補充劑的需求不斷增長也是市場發展的主要驅動力。

此外，老化社會日益增強的健康意識以及對預防醫學日益增長的興趣也推動了市場的擴張。為了滿足日益增長的素食替代品需求，人們正在增加對植物性替代品（包括羥丙基甲基纖維素和木薯澱粉膠囊）等技術創新的投資。同時，製造流程的技術進步有助於增加產品多樣性並提高生產效率。

目錄

第1章 計劃的範圍和定義

第2章 調查手法

第3章 美國的關稅的影響

第4章 摘要整理

第5章 全球軟體凝膠膠囊市場展望，2018年～2032年

  • 市場規模分析與預測
    • 各金額
  • 市場佔有率分析與預測
    • 各材料類型
      • 明膠/動物來歷
      • 非動物來歷
    • 依來歷
      • 豬
      • 牛
      • 其他
    • 各用途
      • 制酸劑·腸胃藥
      • 抗貧血劑
      • 抗發炎藥
      • 抗生素·抗菌藥
      • 止咳藥·感冒藥
      • 健康補充品
      • 維他命·營養補充品
    • 各終端用戶
      • 製藥企業
      • 營養補充品企業
      • 化妝品企業
      • 契約製造組織
    • 各地區
      • 北美
      • 歐洲
      • 亞太地區
      • 南美
      • 中東·非洲
    • 各企業的市場佔有率分析(前五名公司·其他 - 各金額，2024年)
  • 2024年的市場地圖分析
    • 各材料類型
    • 依來歷
    • 各用途
    • 各終端用戶
    • 各地區

第6章 北美的軟體凝膠膠囊市場展望，2018年～2032年

  • 市場規模分析與預測
    • 各金額
  • 市場佔有率分析與預測
    • 各材料類型
      • 明膠/動物來歷
      • 非動物來歷
    • 依來歷
      • 豬
      • 牛
      • 其他
    • 各用途
      • 制酸劑·腸胃藥
      • 抗貧血劑
      • 抗發炎藥
      • 抗生素·抗菌藥
      • 止咳藥·感冒藥
      • 健康補充品
      • 維他命·營養補充品
    • 各終端用戶
      • 製藥企業
      • 營養補充品企業
      • 化妝品企業
      • 契約製造組織
    • 各國佔有率
      • 美國
      • 加拿大
      • 墨西哥
  • 各國市場評估
    • 美國的軟體凝膠膠囊市場展望，2018年～2032年
      • 市場規模分析與預測
      • 市場佔有率分析與預測
    • 加拿大
    • 墨西哥

第7章 歐洲的軟體凝膠膠囊市場展望，2018年～2032年

  • 德國
  • 法國
  • 義大利
  • 英國
  • 俄羅斯
  • 荷蘭
  • 西班牙
  • 波蘭

第8章 亞太地區的軟體凝膠膠囊市場展望，2018年～2032年

  • 印度
  • 中國
  • 日本
  • 澳洲
  • 越南
  • 韓國
  • 印尼
  • 菲律賓

第9章 南美的軟體凝膠膠囊市場展望，2018年～2032年

  • 巴西
  • 阿根廷

第10章 中東·非洲的軟體凝膠膠囊市場展望，2018年～2032年

  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非
  • 以色列

第11章 需求供給分析

第12章 價值鏈分析

第13章 波特的五力分析

第14章 大環境分析

第15章 價格分析

第16章 市場動態

  • 推動市場要素
  • 市場課題

第17章 市場趨勢與發展

第18章 法規結構和革新

  • 臨床試驗
  • 法規當局的認證

第19章 專利的形勢

第20章 案例研究

第21章 競爭情形

  • 前五名市場領導公司的競爭矩陣
  • 前五名公司的SWOT分析
  • 前十大企業的主要企業的形勢
    • Thermo Fisher Scientific Inc.
    • EyePoint Pharmaceuticals, Inc.
    • Catalent, Inc.
    • ProCaps Laboratories, LLC
    • Soft Gel Technologies, Inc.
    • Gelatin, Inc.
    • Narmada Gelatines Limited
    • Xiamen Gelken Gelatin Co., Ltd.
    • Aenova Group
    • Sirio Pharma Co., Ltd.

第22章 策略性建議

第23章 關於調查公司·免責聲明

Product Code: MX13355

Global softgel capsules market is projected to witness a CAGR of 5.45% during the forecast period 2025-2032, growing from USD 2.34 billion in 2024 to USD 3.58 billion in 2032. The growth of the market can be attributed to the rapid expansion of the pharmaceutical industry, increasing investments in research and development activities, and a growing focus on the introduction of novel products and technologies. Softgel capsules are usually preferred due to their ease of swallowing, improved bioavailability, and the ability to mask unpleasant odors and flavors. Increasing customer demand for food supplements such as omega-3 fatty acids, vitamins, and herbal medication is also a major market driver.

Additionally, the market's expansion is also supported by the increasing health consciousness among the aging population and the increasing emphasis on preventive healthcare. Investments in innovations such as plant-based alternatives, including capsules derived from hydroxypropyl methylcellulose and tapioca starch, are being made to address the growing requirement for vegetarian alternatives. Meanwhile, technological advancements in manufacturing processes are aiding in increasing product diversity and improving production efficiency.

Novel Launches Bolster Market Growth

Key manufacturers and leading players in the market are increasingly focusing on launching new formulations to cater to the evolving industry demands and requirements of consumers. Companies across the globe are increasingly focusing on developing vegan and plant-based softgel capsules to appeal to health and environmentally conscious consumers seeking alternatives to traditional capsules. For instance, in May 2024, Roquette Group launched LYCAGEL Flex hydroxypropyl pea starch premix for pharmaceutical and nutraceutical softgel capsules. The premix aids manufacturers in customizing formulations by selecting optimal plasticizer combinations, catering to the diverse requirements of both producers and end-users. Additionally, LYCAGEL Flex addresses the various challenges associated with gelatin-based capsules, including interactions with specific fill types, molecular crosslinking, and sensitivity to heat and moisture.

Moreover, the launch of new products with advanced encapsulation technologies, including the development of delayed-release and enteric-coated softgels are improving the bioavailability and therapeutic efficacy of the medications. These innovations allow for more effective delivery of active ingredients, particularly for sensitive compounds that require protection from gastric acid, increasing physician confidence in the product and bolstering demand.

Rising Collaborations Support Market Expansion

The increase in collaborations between leading pharmaceutical companies to support research and development activities is one of the major drivers of the market, as such efforts allow them to innovate novel therapeutic solutions and leverage one another's strengths, including market reach and technical expertise.

For instance, in February 2025, Jupiter Neurosciences Inc. partnered with Catalent Pharma Solutions LLC to produce JOTROL softgel capsules to support the former's upcoming Phase 2a clinical trial in Parkinson's disease. The trial is going to evaluate the pharmacokinetics/pharmacodynamics, safety, and tolerability of JOTROL over three months. Such collaborations are expected to bolster the availability of novel treatment options for neurodegenerative diseases, propelling the requirement for softgel capsules and providing lucrative growth opportunities for the market.

Such collaborations are also allowing the development of novel softgel products that meet the previously unmet requirements of the patient population. By pooling resources pharmaceutical companies are also able to improve the accessibility and affordability of the end product, allowing them to capture a broader share of the market.

Nutraceutical Companies Account for Significant Share of the Market

The increasing adoption of preventive healthcare approaches is resulting in higher consumption of herbal supplements, omega-3 fatty acids, vitamins, and minerals, which are often formulated in softgel form. These capsules are preferred for nutraceutical applications due to the ease of swallowing offered by these capsules, along with high bioavailability. They also improve the stability of fat-soluble and oil-based nutrients, further increasing their preference for delivering herbal and nutritional ingredients as compared to other tablets and powders.

Additionally, the growing popularity of health and wellness trends, including cognitive functions, gut health, and immunity-boosting supplements, has further increased the demand for softgel capsules. To meet this growing demand, leading nutraceutical companies are increasingly focusing on mergers and acquisitions, new product launches, and research and development activities.

Moreover, the rising investments in the nutraceutical CDMOs are also supporting the segment's growth. For instance, in March 2025, Tirupati Medicare Ltd. received an investment of approximately USD 122 million, allowing them to expand their product portfolio and manufacturing capabilities. Additionally, the investment is also expected to support Tirupati in implementing various inorganic growth strategies and help drive sales.

North America Region Holds Major Market Share

The dominance of the region can be attributed to high consumer awareness of health and wellness products, driven by the growing demand for dietary supplements and nutraceuticals. The United States dominates the North American market, supported by an aging population and increasing demand for supplements targeting chronic disease prevention. According to the estimates of the Population Reference Bureau, the number of individuals aged 65 and above is estimated to increase to 82 million by 2050 from 58 million in 2022. The presence of major pharmaceutical and nutraceutical manufacturers in North America contributes significantly to market growth. Companies in the region invest heavily in research and development to expand their product portfolios, including innovations in non-gelatin and plant-based capsules to cater to diverse consumer preferences. Additionally, advanced production technologies and robust distribution networks, including pharmacies, supermarkets, and online platforms, ensure widespread accessibility of softgel capsules. Moreover, the region benefits from a strong regulatory framework that ensures high-quality production standards, enhancing consumer trust. These factors collectively position North America as a dominant player in the global softgel capsules market.

Future Market Scenario (2025-2032F)

As per the global softgel capsules market analysis, the market's demand is expected to increase significantly in the coming years due to the growing requirement for dietary supplements as health consciousness among consumers rises. Some of the innovations and advancements in the market would include advancements in encapsulation technologies, including nano-emulsion formulations and sustained release. As the preference for sustainability, convenience, and efficacy increases, the market is expected to encounter lucrative growth opportunities.

Meanwhile, the key players in the industry are expected to focus on the expansion of manufacturing facilities, new product launches, and strategic acquisitions to stay competitive in this industry and hold their position.

Key Players Landscape and Outlook

The leading players across the globe are actively investing in launching new products with enhanced features, providing lucrative growth opportunities. For instance, in March 2024, LEE HEALTH DOMAIN (I) PVT. LTD., an Indian nutraceutical company, launched Lyphosterol, a natural polypill supplement for heart care. The soft gel capsule contains bioactive compounds from aged garlic extract, gamma oryzanol, phytosterol, lycopene, nano curcumin, fenugreek, and piperine. These compounds effectively balance cholesterol and triglyceride levels, remove soft plaque in arteries, stabilize irregular heartbeats, protect against free radicals, and reduce heart disease risk.

Additionally, the companies are also engaging in mergers and acquisitions to expand their product portfolios, improve their manufacturing capabilities, and enhance their reach. For instance, in March 2023, Darling Ingredients Inc. completed its acquisition of Gelnex, Inc., a Brazilian gelatin and collagen producer. The acquisition includes five facilities in South America and one in the United States, providing Darling Ingredients with the capacity to produce 46,000 metric tons of gelatin and collagen every year.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Impact of U.S. Tariffs

4. Executive Summary

5. Global Softgel Capsules Market Outlook, 2018-2032F

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Material Type
      • 5.2.1.1. Gelatin/Animal-based
      • 5.2.1.2. Non-Animal-based
    • 5.2.2. By Source
      • 5.2.2.1. Porcine
      • 5.2.2.2. Bovine
      • 5.2.2.3. Others
    • 5.2.3. By Application
      • 5.2.3.1. Antacid and Anti-Flatulent Preparations
      • 5.2.3.2. Anti-Anemic Preparations
      • 5.2.3.3. Anti-Inflammatory Drugs
      • 5.2.3.4. Antibiotic and Antibacterial Drugs
      • 5.2.3.5. Cough and Cold Preparations
      • 5.2.3.6. Health Supplements
      • 5.2.3.7. Vitamin and Dietary Supplements
    • 5.2.4. By End-user
      • 5.2.4.1. Pharmaceutical Companies
      • 5.2.4.2. Nutraceutical Companies
      • 5.2.4.3. Cosmeceutical Companies
      • 5.2.4.4. Contract Manufacturing Organizations
    • 5.2.5. By Region
      • 5.2.5.1. North America
      • 5.2.5.2. Europe
      • 5.2.5.3. Asia-Pacific
      • 5.2.5.4. South America
      • 5.2.5.5. Middle East and Africa
    • 5.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
  • 5.3. Market Map Analysis, 2024
    • 5.3.1. By Material Type
    • 5.3.2. By Source
    • 5.3.3. By Application
    • 5.3.4. By End-user
    • 5.3.5. By Region

6. North America Softgel Capsules Market Outlook, 2018-2032F*

  • 6.1. Market Size Analysis & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share Analysis & Forecast
    • 6.2.1. By Material Type
      • 6.2.1.1. Gelatin/Animal-based
      • 6.2.1.2. Non-Animal-based
    • 6.2.2. By Source
      • 6.2.2.1. Porcine
      • 6.2.2.2. Bovine
      • 6.2.2.3. Others
    • 6.2.3. By Application
      • 6.2.3.1. Antacid and Anti-flatulent Preparations
      • 6.2.3.2. Anti-anemic Preparations
      • 6.2.3.3. Anti-inflammatory Drugs
      • 6.2.3.4. Antibiotic and Antibacterial Drugs
      • 6.2.3.5. Cough and Cold Preparations
      • 6.2.3.6. Health Supplements
      • 6.2.3.7. Vitamin and Dietary Supplements
    • 6.2.4. By End-user
      • 6.2.4.1. Pharmaceutical Companies
      • 6.2.4.2. Nutraceutical Companies
      • 6.2.4.3. Cosmeceutical Companies
      • 6.2.4.4. Contract Manufacturing Organizations
    • 6.2.5. By Country Share
      • 6.2.5.1. United States
      • 6.2.5.2. Canada
      • 6.2.5.3. Mexico
  • 6.3. Country Market Assessment
    • 6.3.1. United States Softgel Capsules Market Outlook, 2018-2032F*
      • 6.3.1.1. Market Size Analysis & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share Analysis & Forecast
        • 6.3.1.2.1. By Material Type
          • 6.3.1.2.1.1. Gelatin/ Animal-based
          • 6.3.1.2.1.2. Non-Animal-based
        • 6.3.1.2.2. By Source
          • 6.3.1.2.2.1. Porcine
          • 6.3.1.2.2.2. Bovine
          • 6.3.1.2.2.3. Others
        • 6.3.1.2.3. By Application
          • 6.3.1.2.3.1. Antacid and Anti-Flatulent Preparations
          • 6.3.1.2.3.2. Anti-Anemic Preparations
          • 6.3.1.2.3.3. Anti-Inflammatory Drugs
          • 6.3.1.2.3.4. Antibiotic and Antibacterial Drugs
          • 6.3.1.2.3.5. Cough and Cold Preparations
          • 6.3.1.2.3.6. Health Supplements
          • 6.3.1.2.3.7. Vitamin and Dietary Supplements
        • 6.3.1.2.4. By End-user
          • 6.3.1.2.4.1. Pharmaceutical Companies
          • 6.3.1.2.4.2. Nutraceutical Companies
          • 6.3.1.2.4.3. Cosmeceutical Companies
          • 6.3.1.2.4.4. Contract Manufacturing Organizations
    • 6.3.2. Canada
    • 6.3.3. Mexico

All segments will be provided for all regions and countries covered

7. Europe Softgel Capsules Market Outlook, 2018-2032F

  • 7.1. Germany
  • 7.2. France
  • 7.3. Italy
  • 7.4. United Kingdom
  • 7.5. Russia
  • 7.6. Netherlands
  • 7.7. Spain
  • 7.8. Poland

8. Asia-Pacific Softgel Capsules Market Outlook, 2018-2032F

  • 8.1. India
  • 8.2. China
  • 8.3. Japan
  • 8.4. Australia
  • 8.5. Vietnam
  • 8.6. South Korea
  • 8.7. Indonesia
  • 8.8. Philippines

9. South America Softgel Capsules Market Outlook, 2018-2032F

  • 9.1. Brazil
  • 9.2. Argentina

10. Middle East and Africa Softgel Capsules Market Outlook, 2018-2032F

  • 10.1. Saudi Arabia
  • 10.2. UAE
  • 10.3. South Africa
  • 10.4. Israel

11. Demand Supply Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

  • 16.1. Market Drivers
  • 16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

  • 18.1. Clinical Trials
  • 18.2. Regulatory Approvals

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

  • 21.1. Competition Matrix of Top 5 Market Leaders
  • 21.2. SWOT Analysis for Top 5 Players
  • 21.3. Key Players Landscape for Top 10 Market Players
    • 21.3.1. Thermo Fisher Scientific Inc.
      • 21.3.1.1. Company Details
      • 21.3.1.2. Key Management Personnel
      • 21.3.1.3. Products and Services
      • 21.3.1.4. Financials (As Reported)
      • 21.3.1.5. Key Market Focus and Geographical Presence
      • 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 21.3.2. EyePoint Pharmaceuticals, Inc.
    • 21.3.3. Catalent, Inc.
    • 21.3.4. ProCaps Laboratories, LLC
    • 21.3.5. Soft Gel Technologies, Inc.
    • 21.3.6. Gelatin, Inc.
    • 21.3.7. Narmada Gelatines Limited
    • 21.3.8. Xiamen Gelken Gelatin Co., Ltd.
    • 21.3.9. Aenova Group
    • 21.3.10. Sirio Pharma Co., Ltd.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

22. Strategic Recommendations

23. About Us and Disclaimer

List of Tables

  • Table 1. Competition Matrix of Top 5 Market Leaders
  • Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 2. Global Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 3. Global Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 4. Global Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 5. Global Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 6. Global Softgel Capsules Market Share (%), By Region, 2018-2032F
  • Figure 7. North America Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 8. North America Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 9. North America Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 10. North America Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 11. North America Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 12. North America Softgel Capsules Market Share (%), By Country, 2018-2032F
  • Figure 13. United States Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 14. United States Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 15. United States Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 16. United States Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 17. United States Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 18. Canada Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 19. Canada Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 20. Canada Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 21. Canada Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 22. Canada Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 23. Mexico Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 24. Mexico Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 25. Mexico Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 26. Mexico Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 27. Mexico Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 28. Europe Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 29. Europe Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 30. Europe Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 31. Europe Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 32. Europe Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 33. Europe Softgel Capsules Market Share (%), By Country, 2018-2032F
  • Figure 34. Germany Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 35. Germany Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 36. Germany Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 37. Germany Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 38. Germany Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 39. France Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 40. France Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 41. France Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 42. France Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 43. France Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 44. Italy Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 45. Italy Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 46. Italy Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 47. Italy Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 48. Italy Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 49. United Kingdom Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 50. United Kingdom Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 51. United Kingdom Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 52. United Kingdom Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 53. United Kingdom Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 54. Russia Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 55. Russia Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 56. Russia Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 57. Russia Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 58. Russia Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 59. Netherlands Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 60. Netherlands Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 61. Netherlands Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 62. Netherlands Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 63. Netherlands Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 64. Spain Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 65. Spain Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 66. Spain Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 67. Spain Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 68. Spain Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 69. Turkey Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 70. Turkey Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 71. Turkey Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 72. Turkey Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 73. Turkey Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 74. Poland Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 75. Poland Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 76. Poland Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 77. Poland Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 78. Poland Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 79. South America Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 80. South America Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 81. South America Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 82. South America Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 83. South America Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 84. South America Softgel Capsules Market Share (%), By Country, 2018-2032F
  • Figure 85. Brazil Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 86. Brazil Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 87. Brazil Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 88. Brazil Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 89. Brazil Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 90. Argentina Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 91. Argentina Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 92. Argentina Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 93. Argentina Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 94. Argentina Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 95. Asia-Pacific Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 96. Asia-Pacific Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 97. Asia-Pacific Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 98. Asia-Pacific Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 99. Asia- Pacific Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 100. Asia-Pacific Softgel Capsules Market Share (%), By Country, 2018-2032F
  • Figure 101. India Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 102. India Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 103. India Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 104. India Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 105. India Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 106. China Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 107. China Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 108. China Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 109. China Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 110. China Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 111. Japan Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 112. Japan Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 113. Japan Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 114. Japan Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 115. Japan Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 116. Australia Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 117. Australia Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 118. Australia Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 119. Australia Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 120. Australia Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 121. Vietnam Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 122. Vietnam Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 123. Vietnam Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 124. Vietnam Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 125. Vietnam Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 126. South Korea Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 127. South Korea Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 128. South Korea Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 129. South Korea Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 130. South Korea Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 131. Indonesia Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 132. Indonesia Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 133. Indonesia Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 134. Indonesia Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 135. Indonesia Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 136. Philippines Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 137. Philippines Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 138. Philippines Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 139. Philippines Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 140. Philippines Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 141. Middle East & Africa Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 142. Middle East & Africa Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 143. Middle East & Africa Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 144. Middle East & Africa Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 145. Middle East & Africa Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 146. Middle East & Africa Softgel Capsules Market Share (%), By Country, 2018-2032F
  • Figure 147. Saudi Arabia Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 148. Saudi Arabia Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 149. Saudi Arabia Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 150. Saudi Arabia Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 151. Saudi Arabia Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 152. UAE Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 153. UAE Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 154. UAE Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 155. UAE Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 156. UAE Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 157. South Africa Softgel Capsules Market, By Value, In USD Billion, 2018-2032F
  • Figure 158. South Africa Softgel Capsules Market Share (%), By Material Type, 2018-2032F
  • Figure 159. South Africa Softgel Capsules Market Share (%), By Source, 2018-2032F
  • Figure 160. South Africa Softgel Capsules Market Share (%), By Application, 2018-2032F
  • Figure 161. South Africa Softgel Capsules Market Share (%), By End-user, 2018-2032F
  • Figure 162. By Material Type Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 163. By Source Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 164. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 165. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 166. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024